Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome
Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome
Not yet recruiting · NCT07257978 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Rett syndrome, X-linked disease, cannabis dependence, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-09 | NCT07257978 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fenix Innovation Group | 2 |
| Neurotech International Limited | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Monash Health | Clayton | Australia | 74 |